324 filings
Page 2 of 17
8-K
neoah2 p58b50
22 Sep 14
Entry into a Material Definitive Agreement
12:00am
8-K
ikswq
18 Sep 14
Regulation FD Disclosure
12:00am
8-K
uoxmx7ahnvb7702tfis
18 Sep 14
Auxilium Pharmaceuticals, Inc. Presents Xiaflex (CCH) Data from Multicord and Retreatment Studies at the Assh Annual Meeting
12:00am
8-K
ghq fnwx52xeeee7m
17 Sep 14
Entry into a Material Definitive Agreement
12:00am
8-K
0qlyr0an 25ip8i
10 Sep 14
Regulation FD Disclosure
12:00am
8-K
ugom6rf5
9 Sep 14
Regulation FD Disclosure
12:00am
8-K
mphe8czs x5peu
28 Aug 14
Auxilium Pharmaceuticals, Inc. to Present
12:00am
8-K
xam6v iogs8
21 Aug 14
Departure of Directors or Certain Officers
12:00am
8-K
hs8x07df
21 Aug 14
Auxilium Pharmaceuticals, Inc. Announces Positive Data from Phase 2A Study of CCH In Patients with Cellulite
12:00am
8-K
zdiuk
18 Aug 14
Entry into a Material Definitive Agreement
12:00am
8-K
4hp3fzxhg9rxca 70zpt
11 Aug 14
Auxilium Pharmaceuticals, Inc. Appoints Andrew Saik
12:00am
8-K
q977ok 8b
7 Aug 14
Second Quarter 2014 Financial Results
12:00am
8-K
ch3 jc2ku8m
5 Aug 14
Other Events
12:00am
8-K
4mkb8ox
31 Jul 14
Regulation FD Disclosure
12:00am
8-K
n81wihe9uk63t
26 Jun 14
Canadian-Domiciled Structure Creates Stronger Financial Position, Competitive Partnering and M&A Platform
12:00am
8-K
q2pun30l3i8am4atf
25 Jun 14
Sobi Files for Eu Approval of Xiapex for Peyronies Disease
12:00am
8-K
44jcvq6fdbanghs2kr
11 Jun 14
Entry into a Material Definitive Agreement
12:00am
8-K
0nv9qwd095rv 284grd
5 Jun 14
Other Events
12:00am
8-K
dlg5w lbrluk1ofz3qcr
2 Jun 14
Departure of Directors or Certain Officers
12:00am
8-K
2t27yf
22 May 14
Submission of Matters to a Vote of Security Holders
12:00am